To validate the accuracy of the single-cell and ST workflows in this study, as well as the robustness of the gene regulatory network screening methodology, and to ensure the consistency of the signaling molecules identified, we acquired an independent dataset of ER+ breast cancer single-cell transcriptomes (Figure S6) for validation purposes. The gene discussed is ESR1; the disease is breast cancer.